中性粒细胞长链非编码RNA表达谱揭示SLE肾脏受累的潜在生物标志物
该研究采用RNA-seq技术筛查SLE患者与健康供者外周血中性粒细胞的差异表达长链非编码RNA(lncRNA),并用实时定量PCR在88例SLE患者、35例其他结缔组织病对照和78例健康对照中验证候选lncRNA。结果显示Lnc-FOSB-1:1在SLE患者中性粒细胞中显著降低,与SLEDAI-2K评分及IFN评分负相关,且基线低水平与基线无肾病患者未来肾脏受累风险升高相关。
要点
- SLE患者中性粒细胞中Lnc-FOSB-1:1表达显著降低,与疾病活动度负相关。
- Lnc-FOSB-1:1降低与狼疮肾炎相关,基线低水平预示未来肾脏受累风险升高。
- Lnc-FOSB-1:1有望作为预测SLE近期肾脏受累的潜在生物标志物。
核心结论
- SLE患者中性粒细胞lncRNA表达谱存在差异,Lnc-FOSB-1:1是预测近期肾脏受累的潜在生物标志物。
研究设计与样本
- 采用RNA-seq技术筛查SLE患者与健康供者中性粒细胞差异表达lncRNA。
- 用实时定量PCR在88例SLE患者、35例其他结缔组织病对照和78例健康对照中验证候选lncRNA。
主要发现
- 与健康对照相比,SLE患者中性粒细胞中360个lncRNA上调、224个下调。
- Lnc-FOSB-1:1在SLE患者中性粒细胞中较其他CTD患者或健康对照显著降低。
- Lnc-FOSB-1:1与SLEDAI-2K评分负相关(r = -0.541,P < 0.001),与IFN评分负相关(r = -0.337,P = 0.001)。
- Lnc-FOSB-1:1降低与狼疮肾炎相关;基线无肾病患者中,基线水平越低,未来(平均2.6年内)肾脏受累风险越高(P = 0.019)。
关键数值与推荐
- qPCR验证样本:88例SLE患者、35例其他结缔组织病对照、78例健康对照。
- Lnc-FOSB-1:1与SLEDAI-2K评分相关系数r = -0.541,P < 0.001。
- Lnc-FOSB-1:1与IFN评分相关系数r = -0.337,P = 0.001。
- 基线无肾病患者未来肾脏受累风险与基线Lnc-FOSB-1:1水平的关联P = 0.019,随访平均2.6年。
临床怎么用
- 对基线无肾脏受累的SLE患者,可关注中性粒细胞Lnc-FOSB-1:1水平以辅助评估近期肾脏受累风险。
- Lnc-FOSB-1:1与SLEDAI-2K及IFN评分负相关,可作为疾病活动度评估的补充参考。
局限性
- 验证队列样本量有限,结论需更大样本及多中心研究证实。
- Lnc-FOSB-1:1预测肾脏受累的机制及其临床阈值尚未明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The long non-coding RNA plays an important role in inflammation and autoimmune diseases. The aim of this study is to screen and identify abnormally expressed lncRNAs in peripheral blood neutrophils of SLE patients as novel biomarkers and to explore the relationship between lncRNAs levels and clinical features, disease activity and organ damage. METHODS: RNA-seq technology was used to screen differentially expressed lncRNAs in neutrophils from SLE patients and healthy donors. Based on the results of screening, candidate lncRNA levels in neutrophils of 88 SLE patients, 35 other connective disease controls, and 78 healthy controls were qualified by real-time quantitative polymerase chain reaction. RESULTS: LncRNA expression profiling revealed 360 up-regulated lncRNAs and 224 down-regulated lncRNAs in neutrophils of SLE patients when compared with healthy controls. qPCR assay validated that the expression of Lnc-FOSB-1:1 was significantly decreased in neutrophils of SLE patients when compared with other CTD patients or healthy controls. It correlated negatively with SLE Disease Activity Index 2000 (SLEDAI-2K) score (r = -0.541, P < 0.001) and IFN scores (r = -0.337, P = 0.001). More importantly, decreased Lnc-FOSB-1:1 expression was associated with lupus nephritis. Lower baseline Lnc-FOSB-1:1 level was associated with higher risk of future renal involvement (within an average of 2.6 years) in patients without renal disease at baseline (P = 0.019). CONCLUSION: LncRNA expression profile in neutrophils of SLE patients revealed differentially expressed lncRNAs. Validation study on Lnc-FOSB-1:1 suggest that it is a potential biomarker for prediction of near future renal involvement.
引用
- Cai B, Cai J, Yin Z, et al. Long non-coding RNA expression profiles in neutrophils revealed potential biomarker for prediction of renal involvement in SLE patients. Rheumatology (Oxford). 2021. PMID: 33068407. doi:10.1093/rheumatology/keaa575
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。